This leaflet explains how to assess chronic liver disease using Samsung’s liver ultrasound technologies. Chronic liver disease, including liver fibrosis and steatosis, presents significant health risks worldwide. Accurate, noninvasive assessment methods are essential for effective diagnosis and monitoring.
Samsung offers advanced liver ultrasound tools, including Tissue Attenuation Imaging (TAI™) and Tissue Scatter Distribution Imaging (TSI™), to evaluate hepatic steatosis by analyzing ultrasound signal properties. Additionally, S-Shearwave Imaging™ provides two-dimensional shear wave elastography, measuring tissue stiffness for liver fibrosis assessment.
The leaflet provides step-by-step scan recommendations, including patient preparation (fasting), positioning, and proper Region of Interest (ROI) placement to ensure reliable measurements. Clinical images highlight real-world applications, such as detecting fatty liver and cirrhosis.
Validated across multiple ultrasound systems like V8, V7, V6 and RS85 Prestige, these tools offer high diagnostic performance, supporting clinicians in evaluating Non-Alcoholic Fatty Liver Disease (NAFLD) and other chronic liver conditions. These solutions reduce the need for invasive procedures like biopsies, making liver health assessment safer and more accessible.
Supported by recent clinical studies and international guidelines, Samsung’s liver ultrasound technologies provide clinicians with effective, repeatable methods for liver disease evaluation.
For a comprehensive overview of TAI™ and TSI™ technologies and their clinical applications in non-invasive fatty liver assessment, please refer to the report: EzHRI™, TAI™ & TSI™ – Non-invasive Quantification Methods of Fatty Liver.
